Abstract
Human embryonic stem cells are commonly derived from the inner cell mass of developing blastocyst-stage embryos. They are capable of unlimited expansion in vitro and can be maintained in culture indefinitely in their undifferentiated state. These cells can also spontaneously differentiate into different cell types that are representative of the three germ layers (ectoderm, mesoderm and endoderm) both in vitro and in vivo, by generating teratomas after injection into immunocompromised mice. The capacity to differentiate into a variety of cells gives them a promising applicability in cell replacement therapies, and makes hESCs powerful tools for studying the molecular mechanisms underlying cellular differentiation. Here, we will describe protocols to derive hESC lines using conventional procedures and in a xeno-free culture condition, as well as discuss the potential therapeutic use of these cells in regenerative medicine and in pharmaceutical drug screening.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chen H, Qian K, Hu J, Liu D, Lu W, Yang Y, Wang D, Yan H, Zhang S, Zhu G (2005) The derivation of two additional human embryonic stem cell lines from day 3 embryos with low morphological scores. Hum Reprod 20:2201–2206
Doss MX, Koehler CI, Gissel C, Hescheler J, Sachinidis A (2004) Embryonic stem cells: a promising tool for cell replacement therapy. J Cell Mol Med 8:465–473
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154–156
Fonseca SAS, Costas RM, Pereira LV (2015a) Searching for naïve human pluripotent stem cells. World J Stem Cells 7(3):649–656
Fonseca SAS, Costas RM, Morato-Marques M, Costa S, Alegretti JR, Rosenberg C, da Motta EL, Serafini PC, Pereira LV (2015b) A euploid line of human embryonic stem cells derived from a 43,XX,dup(9q),+12,-14,-15,-18,-21 Embryo. PLoS One 10(11):e0140999.
Geron Corporation (2009) World’s first clinical trial of human embryonic stem cell therapy cleared. Regen Med 4(2):161
Gosden C, Davdson C, Robertson M (1992) Lymphocyte culture. In: Rooney DE, Czepulkowsky BH (eds) Human cytogenetics. Oxford University Press, Oxford, pp 37–47
Lerou PH, Yabuuchi A, Huo H, Takeuchi A, Shea J, Cimini T, Ince TA, Ginsburg E, Racowsky C, Daley GQ (2008) Human embryonic stem cell derivation from poor-quality embryos. Nat Biotechnol 26:212–214
Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U SA 78:7634–7638
Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, Van de Velde H, De Rycke M, Degreef E, Devroey P, Liebaers I, Van Steirteghem A (2006) Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21:503–511
Maury Y, Gauthier M, Peschanski M, Martinat C (2012) Human pluripotent stem cells for disease modelling and drug screening. Bioessays 34(1):61–71
Melkoumian Z, Weber JL, Weber DM, Fadeev AG, Zhou Y, Dolley-Sonneville P, Yang J, Qiu L, Priest CA, Shogbon C, Martin AW, Nelson J, West P, Beltzer JP, Pal S, Brandenberger R (2010) Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 28:606–610
Mitalipova M, Palmarini G (2006) Isolation and characterization of human embryonic stem cells. Methods Mol Biol 331:55–76
Peura T, Bosman A, Chami O, Jansen RP, Texlova K, Stojanov T (2008) Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos. Cloning Stem Cells 10:203–216
Prokhorova TA, Harkness LM, Frandsen U, Ditzel N, Schoder HD, Burns JS, Kassem M (2009) Teratoma formation by human embryonic stem cells is site-dependent and enhanced by the presence of matrigel. Stem Cells Dev 18(1):47–54
Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399–404
Rodin S, Antonsson L, Niaudet C, Simonson OE, Salmela E, Hansson EM, Domogatskaya A, Xiao Z, Damdimopoulou P, Sheikhi M, Inzunza J, Nilsson AS, Baker D, Kuiper R, Sun Y, Blennow E, Nordenskjold M, Grinnemo KH, Kere J, Betsholtz C, Hovatta O, Tryggvason K (2014) Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat Commun 5:3195
Rodin S, Domogatskaya A, Ström S, Hansson EM, Chien KR, Inzunza J, Hovatta O, Tryggvason K (2010) Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 28:611–615
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713–720
Shetty R, Inamdar MS (2012) Derivation of human embryonic stem cell lines from poor quality embryos. Methods Mol Biol 873:151–161
Silva SS, Rowntree RK, Mekhoubad S, Lee JT (2008) X chomosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci U S A 105:4820–4825
Song M, Paul S, Lim H, Dayem AA, Cho SG (2012) Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening. Arch Pharm Res 35(2):245–260
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Tropel P, Tournois J, Côme J, Varela C, Moutou C, Fragner P, Cailleret M, Laâbi Y, Peschanski M, Viville S (2010) High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis. In Vitro Cell Dev Biol Anim 46:376–385
Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O (2008) Good manufacturing practice and clinicalgrade human embryonic stem cell lines. Hum Mol Genet 17:R48–R53
Villa-Diaz LG, Nandivada H, Ding J, Nogueira-de-Souza NC, Krebsbach PH, O’Shea KS, Lahann J, Smith GD (2010) Synthetic polymer coatings for long-term growth of humanembryonic stem cells. Nat Biotechnol 28:581–583
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Fonseca, S.A.S., Costas, R.M., Pereira, L.V. (2016). Human Embryonic Stem Cell Line Derivation. In: Working with Stem Cells. Springer, Cham. https://doi.org/10.1007/978-3-319-30582-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-30582-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30580-6
Online ISBN: 978-3-319-30582-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)